Rep. Davis Introduces Bipartisan Bill to Add Chemical Trackers to Prescription Pills to Fight Counterfeits
This bill is sitting in the House Committee on Energy and Commerce where it must be reviewed before it can move forward. Nothing has happened with this bill since February 2025. Because no action has occurred for over 17 months, the bill is considered stalled.
While the bill has support from both parties, most standalone bills struggle to get a full vote in Congress unless they are part of a larger package.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 4988 (118th), which died when its Congress ended.
H.R. 4988 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Independent pharmacies and small pharmaceutical distributors would need to invest in new verification equipment capable of reading chemical identifiers. While this adds cost and complexity, it also gives small pharmacies a tool to verify drug authenticity, which could help them compete by offering stronger safety assurances to customers.
“determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B).”
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Sponsor introductory remarks on measure. (CR H519)
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Modern Authentication of Pharmaceuticals Act of 2025
Analysis generated by AI. Always verify with official sources.